| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/14/2008 | WO2008018488A1 Antibacterial agent |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008017867A2 Antiretroviral solid oral composition with at least one water insoluble polymer |
| 02/14/2008 | WO2008017826A2 Immunogenic proteins of burkholderia pseudomallei and uses thereof |
| 02/14/2008 | WO2008017734A1 Polymyxin derivatives and uses thereof |
| 02/14/2008 | WO2008017692A2 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 02/14/2008 | WO2008017688A1 2-carboxy thiophene derivatives as anti-viral agents |
| 02/14/2008 | WO2008017568A1 Plasmids with immunological action |
| 02/14/2008 | WO2008017473A2 Structure and use of 5' phosphate oligonucleotides |
| 02/14/2008 | WO2008017264A1 Pharmaceutical composition comprising methyl donors or methyl donor enhancers and anti-viral compounds |
| 02/14/2008 | WO2007149891A3 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 02/14/2008 | WO2007140200A3 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 02/14/2008 | WO2007139955A8 Triazole compounds that modulate hsp90 activity |
| 02/14/2008 | WO2007136302A3 Active substances, pharmaceutical composition and a method for the production and use thereof |
| 02/14/2008 | US20080039611 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039532 Compounds For Specific Viral Target |
| 02/14/2008 | US20080039508 Treatment Of Tumours |
| 02/14/2008 | US20080039488 Salt of naphthyridine carboxylic acid derivative |
| 02/14/2008 | US20080039487 Processes and intermediates useful for preparing integrase inhibitor compounds |
| 02/14/2008 | US20080039486 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 02/14/2008 | US20080039470 Acylaminoheteroaryl hepatitis C virus protease inhibitors |
| 02/14/2008 | US20080039459 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039438 1B-Methylcarbapenem Derivative and Process for the Preparation Thereof |
| 02/14/2008 | US20080039428 Antiretroviral combination therapy |
| 02/14/2008 | US20080039410 Inositol 1,4,5-Trisphosphate Receptor Mutants and Uses Thereof |
| 02/14/2008 | US20080039407 Antibiotic and Method of Production Thereof |
| 02/14/2008 | US20080039406 3,6-bridged tylosin derivatives |
| 02/14/2008 | US20080039374 Cross-lined glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038382 Extracts of Scutellaria for the Treatment of Sars |
| 02/14/2008 | US20080038374 New Use |
| 02/14/2008 | US20080038356 Spray freeze-dried compositions |
| 02/14/2008 | US20080038330 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 02/14/2008 | US20080038322 Stabilized Bacteriophage Formulations |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038297 Genetic adjuvants for viral vaccines |
| 02/14/2008 | US20080038295 Compositions and methods for orthopox virus vaccination |
| 02/14/2008 | US20080038293 compositions provide immune response up to and including protective immunity against porcine reproductive and respiratory syndrome (PRRS) as well as reduce the severity of PRRS virus (PRRSV) and/or incidence of PRRSV |
| 02/14/2008 | US20080038287 Method For Identification, Isolation and Production of Antigens to a Specific Pathogen |
| 02/14/2008 | US20080038283 Methods of Evaluating Efficacy of an Immune Response by Assesing Alpha-1 Integrin Expression |
| 02/14/2008 | US20080038280 A32 Monoclonal Antibody Fusion Proteins For Use As Hiv Inhibitors And Vaccines |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038266 Antibody or antigen binding fragment that binds acetyl-coA-acetyltransferase of Clostridium difficile |
| 02/14/2008 | US20080038226 Culture Methods for Cryptosporidium |
| 02/14/2008 | US20080038225 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | US20080038224 Modified interferon-beta (IFN-beta) polypeptides |
| 02/14/2008 | US20080038223 WSX-1/P28 as a target for anti-inflammatory responses |
| 02/14/2008 | US20080038222 Composition Comprising Colony Stimulating Factor for Treatment of a Localised Bacterial Infection and Bacterial Related Disease |
| 02/14/2008 | US20080038201 Global regulator of morphogenesis and pathogenicity in dimorphic fungi and uses thereof |
| 02/14/2008 | US20080038193 Antibodies for use in targeted and temporary treatment of humans and animals |
| 02/14/2008 | US20080035155 Topical Antiviral Formulations |
| 02/14/2008 | DE102006037920A1 Spezielle Carbonylbisimino-Verbindungen zur Behandlung von Immunerkrankungen Carbonylbisimino specific compounds for the treatment of immune diseases |
| 02/14/2008 | CA2694289A1 Polymyxin derivatives and uses thereof |
| 02/14/2008 | CA2660324A1 Plasmids with immunological action |
| 02/14/2008 | CA2660232A1 Structure and use of 5' phosphate oligonucleotides |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/13/2008 | EP1887084A1 Plasmids with immunological action |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1886993A1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 02/13/2008 | EP1886685A1 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| 02/13/2008 | EP1886682A1 Method for preparation of aqueous doripenem solution |
| 02/13/2008 | EP1886681A2 New nuclear transcription factors regulators |
| 02/13/2008 | EP1886677A1 Use of an inducing agent for the treatment of blood, viral and cellular disorders |
| 02/13/2008 | EP1886668A1 Controlled release compositions for interferon based on block polymers |
| 02/13/2008 | EP1885745A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 02/13/2008 | EP1885734A2 Immunogens for meningitidis-a vaccines |
| 02/13/2008 | EP1885716A1 Thiazole derivatives and use thereof |
| 02/13/2008 | EP1885687A2 Tigecycline and methods of preparing 9-nitrominocycline |
| 02/13/2008 | EP1885686A2 Tigecycline and methods of preparing 9-aminominocycline |
| 02/13/2008 | EP1885403A2 Polyethylene glycol cojugates of antimicrobial agents |
| 02/13/2008 | EP1885358A2 TRICYCLIC 6-ALKYLIDENE-PENEMS AS CLASS-D ß-LACTAMASES INHIBITORS |
| 02/13/2008 | EP1885357A1 Bicyclic 6-alkylidene-penems as class-d beta-lactamases inhibitors |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1827482A4 Novel uses of egf |
| 02/13/2008 | EP1578915A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 02/13/2008 | EP1572220B1 Antiviral properties of extracts of dichrostachys glomerata |
| 02/13/2008 | EP1553940B1 Parenteral formulations containing a rapamycin hydroxyester |
| 02/13/2008 | EP1513539B1 Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1476752A4 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1454137B1 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1436010B1 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions, and methods |
| 02/13/2008 | EP1432677B1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 02/13/2008 | EP1414820B1 Non-nucleoside reverse transcriptase inhibitors |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1292328B1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 02/13/2008 | EP1233770B1 Phosphonate compounds |
| 02/13/2008 | EP1105467B9 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 02/13/2008 | EP0906335B1 Ebv type b ctl epitopes |
| 02/13/2008 | EP0837928B1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 02/13/2008 | EP0758244B2 Controlled-release dosage forms of azithromycin |
| 02/13/2008 | CN201020128Y Health-care rhinobyon |